NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,981 | -58.6% | 19,158 | -22.9% | 0.00% | – |
Q2 2023 | $12,019 | -14.5% | 24,858 | +16.6% | 0.00% | – |
Q1 2023 | $14,056 | -72.8% | 21,326 | -54.1% | 0.00% | – |
Q4 2022 | $51,619 | -38.5% | 46,504 | -59.1% | 0.00% | – |
Q3 2022 | $84,000 | -19.2% | 113,584 | -34.3% | 0.00% | – |
Q2 2022 | $104,000 | +25.3% | 172,923 | +410.3% | 0.00% | – |
Q1 2022 | $83,000 | +176.7% | 33,888 | +441.4% | 0.00% | – |
Q4 2021 | $30,000 | -57.1% | 6,259 | -17.4% | 0.00% | – |
Q3 2021 | $70,000 | – | 7,574 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 325,000 | $84,500 | 0.06% |
Texas Capital Bank Wealth Management Services Inc | 63,290 | $16,455 | 0.00% |
XTX Topco Ltd | 11,809 | $3,070 | 0.00% |
United Asset Strategies, Inc. | 18,300 | $4,758 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $41,782 | 0.00% |
UBS Group AG | 1,210 | $315 | 0.00% |
NewEdge Advisors, LLC | 7,125 | $1,853 | 0.00% |
Lido Advisors, LLC | 13,000 | $3,380 | 0.00% |
OSAIC HOLDINGS, INC. | 11,125 | $2,891 | 0.00% |
WELLS FARGO & COMPANY/MN | 5,379 | $1,399 | 0.00% |